XDH and chronic obstructive pulmonary disease: Although higher XO activity in COPD airways does not necessarily reflect its circulating levels in peripheral blood, as XO is a rate-limiting enzyme of purine catabolism with UA being the final product in humans, the scenario involving an increased XO is more likely to be applied in our context with elevated UA (and UCR) levels present in patients’ sera.